Investment Partners, Ltd. Biogen Inc. Transaction History

Investment Partners, Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$264.77 - $305.71 $291,247 - $336,281	-1,100 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$268.85 - $341.04 $26,885 - $34,104	100 Added 10.0%	1,100 $348,000
Q4 2019 Jan 31, 2020	SELL	$220.06 - $304.07 $22,006 - $30,407	-100 Reduced 9.09%	1,000 $297,000
Q2 2019 Jul 30, 2019	BUY	$219.29 - $241.72 $21,929 - $24,172	100 Added 10.0%	1,100 $257,000
Q1 2019 May 03, 2019	SELL	$216.71 - $338.96 $21,671 - $33,896	-100 Reduced 9.09%	1,000 $236,000
Q3 2018 Oct 25, 2018	BUY	$293.51 - $383.83 $29,351 - $38,383	100 Added 10.0%	1,100 $353,000
Q3 2017 Oct 30, 2017	BUY	$281.15 - $329.69 $281,150 - $329,690	1,000	1,000 $313,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Investment Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Investment Partners, Ltd. with notifications on news.